Table 1.
Laboratory values on Days 8, 12 (day of ER admission), and 13 (day of ICU admission) after the initiation of pazopanib therapy
| Parameter | Reference range | Day 8 | Day 12 | Day 13 |
|---|---|---|---|---|
| WBC,/µL | 3,300–8,600 | 4,400 | 6,200 | 3,300 |
| RBC, × 104/µL | 386–492 | 459 | 441 | 474 |
| Hb, g/dL | 11.6–14.8 | 13.3 | 12.9 | 13.5 |
| Platelets, × 104/µL | 15.8–34.8 | 26.9 | 3.6 | 3.0 |
| PT, % | 73–140 | − | 65 | 52 |
| PT-INR | 0.87–1.12 | − | 1.20 | 1.35 |
| FDP,/µg/mL | 0–5 | − | 41.6 | 54.9 |
| AST, U/L | 13–30 | 17 | 277 | 339 |
| ALT, U/L | 7–23 | 10 | 66 | 83 |
| LDH, U/L | 124–222 | 247 | 1,380 | 1,762 |
| ALB, g/dL | 4.1–5.1 | 3.8 | 3.4 | 2.4 |
| BUN, mg/dL | 8.0–20.0 | 19.5 | 57.5 | 64.7 |
| Cr, mg/dL | 0.46–0.79 | 0.80 | 2.30 | 2.95 |
| UA, mg/dL | 2.6–5.5 | − | − | 10.1 |
| CRP, mg/dL | 0–0.14 | 0.60 | 19.56 | 22.21 |
| Na, mEq/L | 138–145 | 139 | 131 | 131 |
| K, mEq/L | 3.6–4.8 | 4.5 | 4.0 | 4.4 |
| Ca, mg/dL | 8.8–10.1 | 9.2 | 8.5 | 7.0 |
| P, mg/dL | 2.7–4.6 | 3.3 | − | 5.9 |
ALB, albumin; ALT, alanine phosphatase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; Ca, calcium; Cr, creatinine; CRP, C-reactive protein; ER, emergency room; FDP, fibrinogen/fibrin degradation product; Hb, hemoglobin; ICU, intensive care unit; INR, international normalized ratio; K, potassium; LDH, lactate dehydrogenase; Na, sodium; P, phosphorus; PT, prothrombin time; RBC, red blood cell count; UA, uric acid; WBC, white blood cell count.